Found 3 hits of ic50 for monomerid = 50396810 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Serine/threonine-protein kinase mTOR
(Homo sapiens (Human)) | BDBM50396810
(CHEMBL2170098 | US8772480, 162)Show SMILES COc1cncc(Nc2ncc(CN3CCN(CC3)S(C)(=O)=O)cc2-c2nc(C)nc(N)n2)c1 Show InChI InChI=1S/C21H27N9O3S/c1-14-25-20(28-21(22)26-14)18-8-15(13-29-4-6-30(7-5-29)34(3,31)32)10-24-19(18)27-16-9-17(33-2)12-23-11-16/h8-12H,4-7,13H2,1-3H3,(H,24,27)(H2,22,25,26,28) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| US Patent
| n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc.
US Patent
| Assay Description The Invitrogen (Carlsbad, Calif.) mammalian target of rapamycin (mTOR) Lanthascreen assay can be used to quantitate mTOR kinase activity in an in vit... |
US Patent US8772480 (2014)
BindingDB Entry DOI: 10.7270/Q2V123FJ |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 3-kinase catalytic subunit type 3
(Homo sapiens (Human)) | BDBM50396810
(CHEMBL2170098 | US8772480, 162)Show SMILES COc1cncc(Nc2ncc(CN3CCN(CC3)S(C)(=O)=O)cc2-c2nc(C)nc(N)n2)c1 Show InChI InChI=1S/C21H27N9O3S/c1-14-25-20(28-21(22)26-14)18-8-15(13-29-4-6-30(7-5-29)34(3,31)32)10-24-19(18)27-16-9-17(33-2)12-23-11-16/h8-12H,4-7,13H2,1-3H3,(H,24,27)(H2,22,25,26,28) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description Inhibition of human VPS34 |
J Med Chem 55: 7796-816 (2012)
Article DOI: 10.1021/jm300846z BindingDB Entry DOI: 10.7270/Q2028SPT |
More data for this Ligand-Target Pair | |
Serine/threonine-protein kinase mTOR
(Homo sapiens (Human)) | BDBM50396810
(CHEMBL2170098 | US8772480, 162)Show SMILES COc1cncc(Nc2ncc(CN3CCN(CC3)S(C)(=O)=O)cc2-c2nc(C)nc(N)n2)c1 Show InChI InChI=1S/C21H27N9O3S/c1-14-25-20(28-21(22)26-14)18-8-15(13-29-4-6-30(7-5-29)34(3,31)32)10-24-19(18)27-16-9-17(33-2)12-23-11-16/h8-12H,4-7,13H2,1-3H3,(H,24,27)(H2,22,25,26,28) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description Inhibition of mTOR |
J Med Chem 55: 7796-816 (2012)
Article DOI: 10.1021/jm300846z BindingDB Entry DOI: 10.7270/Q2028SPT |
More data for this Ligand-Target Pair | |